IL44877A - Allopurinol tablet formulation - Google Patents

Allopurinol tablet formulation

Info

Publication number
IL44877A
IL44877A IL44877A IL4487774A IL44877A IL 44877 A IL44877 A IL 44877A IL 44877 A IL44877 A IL 44877A IL 4487774 A IL4487774 A IL 4487774A IL 44877 A IL44877 A IL 44877A
Authority
IL
Israel
Prior art keywords
tablet formulation
allopurinol
formulation according
agent
particle size
Prior art date
Application number
IL44877A
Other languages
English (en)
Other versions
IL44877A0 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL44877A0 publication Critical patent/IL44877A0/xx
Publication of IL44877A publication Critical patent/IL44877A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL44877A 1973-05-23 1974-05-22 Allopurinol tablet formulation IL44877A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2462873A GB1460302A (en) 1973-05-23 1973-05-23 Tablet formulation

Publications (2)

Publication Number Publication Date
IL44877A0 IL44877A0 (en) 1974-07-31
IL44877A true IL44877A (en) 1976-11-30

Family

ID=10214700

Family Applications (1)

Application Number Title Priority Date Filing Date
IL44877A IL44877A (en) 1973-05-23 1974-05-22 Allopurinol tablet formulation

Country Status (21)

Country Link
JP (1) JPS577128B2 (de)
AT (1) AT351167B (de)
AU (1) AU469472B2 (de)
BE (1) BE815409A (de)
CA (1) CA977279A (de)
CY (1) CY941A (de)
DE (1) DE2424950A1 (de)
DK (1) DK144261C (de)
FI (1) FI156674A (de)
FR (1) FR2230341B1 (de)
GB (1) GB1460302A (de)
HK (1) HK1378A (de)
HU (1) HU170656B (de)
IE (1) IE39283B1 (de)
IL (1) IL44877A (de)
IT (1) IT8048966A0 (de)
KE (1) KE2808A (de)
MY (1) MY7800181A (de)
NL (1) NL190436C (de)
SE (1) SE402525C (de)
ZA (1) ZA743318B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1533243A (en) * 1975-02-13 1978-11-22 Wellcome Found Tablet formulation
US4143129A (en) 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
US4115563A (en) * 1977-03-14 1978-09-19 Sterling Drug Inc. Pharmaceutical steroid formulation
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
DE3839825A1 (de) * 1988-11-25 1990-06-13 Henning Berlin Gmbh Feststoffdispersionen enthaltend oxipurinol und/oder seine alkali- oder erdalkalisalze
WO1996002234A1 (es) * 1994-07-18 1996-02-01 Luis Cipriano Carvajal Martin Granulos compactos altamente autodisgregantes para uso en formas galenicas conteniendo principios activos insolubles o poco solubles

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB975850A (en) * 1955-08-10 1964-11-18 Wellcome Found Xanthine oxidase inhibitors
US3624205A (en) * 1967-04-25 1971-11-30 Burroughs Wellcome Co Treatment of hyperuricemia in humans

Also Published As

Publication number Publication date
IT8048966A0 (it) 1980-06-13
JPS577128B2 (de) 1982-02-09
NL7406873A (de) 1974-11-26
FR2230341B1 (de) 1977-04-15
KE2808A (en) 1978-02-17
NL190436C (nl) 1994-03-01
HU170656B (de) 1977-07-28
JPS5040721A (de) 1975-04-14
CA977279A (en) 1975-11-04
SE402525C (sv) 1982-11-22
DK144261C (da) 1991-02-04
DE2424950A1 (de) 1974-12-19
FI156674A (de) 1974-11-24
HK1378A (en) 1978-01-13
CY941A (en) 1978-06-23
AU6925274A (en) 1975-11-27
FR2230341A1 (de) 1974-12-20
SE402525B (sv) 1978-07-10
DK144261B (de) 1982-02-01
IL44877A0 (en) 1974-07-31
IE39283B1 (en) 1978-09-13
MY7800181A (en) 1978-12-31
ZA743318B (en) 1975-05-28
AU469472B2 (en) 1976-02-12
AT351167B (de) 1979-07-10
NL190436B (nl) 1993-10-01
ATA426774A (de) 1978-12-15
GB1460302A (en) 1977-01-06
IE39283L (en) 1974-11-23
BE815409A (fr) 1974-11-22

Similar Documents

Publication Publication Date Title
ES430431A1 (es) Varistor de oxido metalico.
GB1405088A (en) Slow release formulation
GB1421964A (en) Process for the production of sustained release pharmaceutical preparations
IL44877A (en) Allopurinol tablet formulation
GB1500441A (en) Fertilizer
EP0237241A3 (de) Komprimierte Tabletten mit Kalziumzusatzstoff
GB1464200A (en) Pharmaceutical composition
IE32612L (en) Pharmaceutical composition
GB1191246A (en) Vitamin-containing Preparations
GB1221633A (en) Compositions for hardening teeth and bones
GB1318478A (en) Cephalexin salts
GB1268146A (en) Improvements in or relating to a contraceptive cervical obturator
GB1507867A (en) Edible bran and to a solid edible bran-containing composition and to a process for producing the composition
GB1347140A (en) Sodium tripolyphosphate
US3524917A (en) Tablets of magnesium probenecid tetrahydrate
AU571048B2 (en) Preparing free-flowing particulate yeast
GB1153324A (en) Sustained Release Tablets
IL43562A (en) Pharmaceutical formulations containing allopurinol as inhibitor of xanthine oxidase
GB1287433A (en) Pharmaceutical compositions
US3655742A (en) Process for producing magnesium probenecid tetrahydrate
GB1243562A (en) Process for the production of coloured coatings
IE34705L (en) Reducing deterioration in hay or straw.
GB256053A (en) Soap tablets and process of making the same
GB1212119A (en) Fecal softener
GB1201736A (en) Novel therapeutic composition